d3-testosterone

N/A

Report date: 2026/04/16 20:00:17
NMEFirst In Class

Base Information

Drug Named3-testosterone
Drug Alias Named3-testosterone (Lennham Pharmaceuticals)Deuterated testosteroned3-TAVA-291
ClassificationSmall molecules > Steroids
Mechanisms of ActionAndrogen Receptor agonists
TargetsAndrogen Receptor
Therapy Area/IndicationsGynecomastiaSexual Dysfunction, PhysiologicalBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLennham Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesLennham Pharmaceuticals IncAviva Biopharm Inc
Inactive CompaniesN/A
Active IndicationsGynecomastiaSexual Dysfunction, PhysiologicalBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia